Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria

Naila Rabbani, Antonysunil Adaikalakoteswari, Kasper Rossing, Peter Rossing, Lise Tarnow, Hans Henrik Parving, Paul J. Thornalley^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review